Tingrong Wang

Antihyperalgesic Effects of (R,E)-N-(2-Hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a Novel Transient Receptor Potential Vanilloid Type 1 Modulator That Does Not Cause Hyperthermia in Rats

J. Louis, B. H. Manning, N. Gavva, 2008, Journal of Pharmacology and Experimental Therapeutics.

neonatal myocardial protection The role of cardioplegia induction temperature and amino acid enrichment in

B. Allen, S. Prasad, M. Ilbawi, 2013 .

Effects of ischemic preconditioning on local hemodynamics and isokinetic muscular function

Kuei-Hui Chan, Tingrong Wang, Bo-Huei Huang, 2020 .

TRPV1 modulator that does not cause hyperthermia in rats

J. Louis, B. H. Manning, N. Gavva, 2008 .

Prevention of the hypoxic reoxygenation injury with the use of a leukocyte-depleting filter.

B. Allen, H. Feinberg, K. Bolling, 1997, The Journal of thoracic and cardiovascular surgery.

Antihyperalgesic Effects of (R,E)-N-(2-Hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a Novel Transient Receptor Potential Vanilloid Type 1 Modulator That Does Not Cause Hyperthermia in Rats

J. Louis, B. H. Manning, N. Gavva, 2008, Journal of Pharmacology and Experimental Therapeutics.

Controlled reperfusion prevents pulmonary injury after 24 hours of lung preservation.

B. Allen, S. Rahman, M. Kronon, 1998, The Annals of thoracic surgery.

Myocardial protection in normal and hypoxically stressed neonatal hearts: the superiority of hypocalcemic versus normocalcemic blood cardioplegia.

B. Allen, R. Hartz, H. Feinberg, 1996, The Journal of thoracic and cardiovascular surgery.

Reducing postischemic reperfusion damage in neonates using a terminal warm substrate-enriched blood cardioplegic reperfusate.

B. Allen, M. Ilbawi, K. Bolling, 2000, The Annals of thoracic surgery.